Sufentanil Citrate Market: By Applications & By Geography - Forecast 2016-2021

  • ID: 3973939
  • Report
  • 149 pages
  • IndustryARC
1 of 3
Sufentanil, also known as R30730 or brand name Sufenta, is a synthetic opioid analgesic drug which is considerably more potent than its parent drug, fentanyl, morphine. It is used for producing anesthesia for surgery. It may also be used with other medicines as part of epidural anesthesia during labor and delivery to decrease pain. Globally, development of efficient and advanced technology and increase in number of medical surgeries and gynaecological surgeries are the prime growth drivers of global Sufentanil Citrate market. Apart from this, augmentation in cardiovascular diseases and associated surgeries, and emerging economies are expected to be the key growth drivers during the period of study.

Geographically North America dominates the sufentanil citrate market driven by best in class infrastructure, easy access to healthcare, higher awareness amongst physicians about the advanced technological treatment, higher spending on R&D by large pharmaceutical players in the region and higher spending by the citizens towards healthcare expenditure. North America was followed by Europe and Asia-Pacific as second and third largest market for sufentanil citrate market. Asia Pacific is projected to have the fastest growth, owing to rapidly developing medical infrastructure, increasing medical tourism, increased spending, and increasing awareness amongst population in developing nations such as China and India in this region.

This report identifies the global Sufentanil Citrate market size in for the year 2014-2016, and forecast of the same for year 2021. It also highlights the market drivers, restraints, growth indicators, challenges, and other key aspects with respect to global Sufentanil Citrate market.

This report segments global Sufentanil Citrate market on the basis of type, procedures, and regional market as follows:
This report on global Sufentanil Citrate Market is segmented on the basis of major applications of sulfentanil citrate. Some of the major applications of sulfantanil citrate covered in this report as follows: Surgery, Epidural Anaesthesia and Medicinal Application and for nutraceuticals
This report has been further segmented into major regions, which includes detailed analysis of each region such as: North America, Europe, Asia-Pacific (APAC), and Rest of the World (RoW) covering all the major country level markets in each of the region
This report identifies all the major companies operating in the Sufentanil Citrate market. Some of the major companies’ profiles in detail are as follows:
Wuhan Fengzhulin
Spectrum
Macfarlan Smith
Mallinckrodt Pharmaceuticals
Akorn, Inc
Please Note: The report is to be delivered in 1-2 working days after an order is placed.
READ MORE
Note: Product cover images may vary from those shown
2 of 3
1. Sufentanil Citrate Market – Overview

2. Executive Summary

3. Sufentanil Citrate Market Landscape
3.1. Market Share Analysis
3.2. Comparative Analysis
3.3. Product Benchmarking
3.4. End User Profiling
3.5. Top 5 Financials Analysis

4. Sufentanil Citrate Market– Forces
4.1. Drivers
4.1.1. Development of efficient and advance technology
4.1.2. Increase in number of medical surgeries/Increase in gynaecological surgeries
4.2. Restraints
4.2.1. Higher cost of interventional devices
4.3. Opportunities
4.3.1. Augmentation in cardiovascular diseases and associated surgeries
4.4. Challenges
4.5. Porter’s Five Forces Analysis
4.5.1. Bargaining Power of Suppliers
4.5.2. Bargaining Power of Buyers
4.5.3. Threat of New Entrants
4.5.4. Threat of Substitutes
4.5.5. Degree of Competition

5. Sufentanil Citrate Market– Strategic Analysis
5.1. Value Chain Analysis
5.2. Pricing Analysis
5.3. Opportunities Analysis
5.4. Product/Market Life Cycle Analysis
5.5. Suppliers and Distributors

6. Sufentanil Citrate Market, By Applications
6.1. Surgery
6.2. Epidural Anaesthesia
6.3. Medicinal Application
6.4. Others

7. Sufentanil Citrate Market, By Geography
7.1. Europe
7.1.1. Germany
7.1.2. France
7.1.3. Italy
7.1.4. Spain
7.1.5. Russia
7.1.6. U.K.
7.1.7. Rest of Europe
7.2. Asia Pacific
7.2.1. China
7.2.2. India
7.2.3. Japan
7.2.4. South Korea
7.2.5. Rest of Asia-Pacific
7.3. North America
7.3.1. U.S.
7.3.2. Canada
7.3.3. Mexico
7.4. Rest of the World (RoW)
7.4.1. Brazil
7.4.2. Rest of RoW

8. Sufentanil Citrate – Market Entropy
8.1. Expansion
8.2. Technological Developments
8.3. Merger & Acquisitions, and Joint Ventures
8.4. Supply- Contract

9. Company Profiles (Overview, Financials, SWOT Analysis, Developments, Product Portfolio)
9.1. Akorn, Inc
9.2. Mallinckrodt Pharmaceuticals
9.3. Wuhan Fengzhulin
9.4. Spectrum
9.5. Macfarlan Smith
9.6. EuroCept
9.7. IDT Biologika
*More than 40 Companies are profiled in this Research Report, Complete List available on Request*
"*Financials would be provided on a best efforts basis for private companies"

10. Appendix
10.1. Abbreviations
10.2. Sources
10.3. Research Methodology
10.4. Bibliography
10.5. Compilation of Expert Insights
10.6. Disclaimer
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
Note: Product cover images may vary from those shown
Adroll
adroll